Not available
Quote | Edwards Lifesciences Corporation (NYSE:EW)
Last: | $87.99 |
---|---|
Change Percent: | -0.21% |
Open: | $86.68 |
Close: | $87.99 |
High: | $88.5 |
Low: | $86.5 |
Volume: | 2,689,934 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | Edwards Lifesciences Corporation (NYSE:EW)
2024-07-18 11:34:12 ET More on Health Care Select Sector SPDR® Fund ETF: XLV: A Strong Way To Benefit From An Aging And Unhealthy Population XLV: Healthcare Is Ripe For Buying, Despite Patent Cliff XLV: Pivotal Week Of Earnings For Healthcare Stocks BofA...
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2024 after the market closes on Wednesday, July 24, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877)...
Message Board Posts | Edwards Lifesciences Corporation (NYSE:EW)
Subject | By | Source | When |
---|---|---|---|
Written May 23, 2022 - Update On NIS/EW | JonnyRBuck12 | investorshub | 05/25/2022 11:19:00 PM |
March 30, 2022 Article - NIS Moving Ahead | JonnyRBuck12 | investorshub | 03/31/2022 2:10:43 AM |
Not surprised that EW hit a multi year | JonnyRBuck12 | investorshub | 03/24/2022 12:26:03 AM |
whytestocks: $EW News Article - Trend Tracker for Edwards Lifesciences EW | whytestocks | investorshangout | 08/20/2021 12:30:46 PM |
East West Petroleum Provides Operational Update for New Zealand | JonnyRBuck12 | investorshub | 08/11/2021 3:25:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2024 after the market closes on Wednesday, July 24, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877)...
Edwards Lifesciences (NYSE: EW) today announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve replacement (TMVR) company, following its initial investment in 2017. Since that time, Innovalve has demonstrated progress in its program wi...
2024-07-08 19:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...